Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Cubbon

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
Biochemical and Biophysical Research Communications|October 15, 2024
Insulin receptor signalling in PDGFRβ-expressing cells influences systemic metabolism and negatively impacts lipid storageNele Warmke, Katherine I Bridge, Claire H Ozber, et al.
BMJ Open|July 20, 2019
Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Diabetes Care|October 7, 2017
Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With DiabetesKlaus K Witte, Michael Drozd, Andrew M N Walker, et al.
Journal of the American Heart Association|October 30, 2018
Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection FractionAndrew M N Walker, Michael Drozd, Marlous Hall, et al.
Journal of the American Heart Association|October 30, 2018
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionBen N Mercer, Aaron Koshy, Michael Drozd, et al.
Diabetes & Vascular Disease Research|November 10, 2011
Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary eraMatthew B Kahn, Richard M Cubbon, Ben Mercer, et al.
Vascular Biology (Bristol, England)|October 14, 2024
Whole-body insulin resistance leads to accelerated atherosclerosis: role for Nox2 NADPH oxidaseAzhar Maqbool, Hema Viswambharan, Anna Skromna, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2023
Independent endothelial functions of PIEZO1 and TRPV4 in hepatic portal vein and predominance of PIEZO1 in mechanical and osmotic stressNaima Endesh, Eulashini Chuntharpursat-Bon, Charlotte Revill, et al.
European Journal of Heart Failure|February 12, 2025
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort studyHugo MacGowan, Oliver I Brown, Michael Drozd, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Plos One|December 13, 2021
Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trialMaria F Paton, John Gierula, Judith E Lowry, et al.
Biochemical and Biophysical Research Communications|October 15, 2024
Insulin receptor signalling in PDGFRβ-expressing cells influences systemic metabolism and negatively impacts lipid storageNele Warmke, Katherine I Bridge, Claire H Ozber, et al.
BMJ Open|July 20, 2019
Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trialMaria F Paton, John Gierula, Haqeel A Jamil, et al.
Diabetes Care|October 7, 2017
Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With DiabetesKlaus K Witte, Michael Drozd, Andrew M N Walker, et al.
Journal of the American Heart Association|October 30, 2018
Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection FractionAndrew M N Walker, Michael Drozd, Marlous Hall, et al.
Journal of the American Heart Association|October 30, 2018
Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection FractionBen N Mercer, Aaron Koshy, Michael Drozd, et al.
Diabetes & Vascular Disease Research|November 10, 2011
Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary eraMatthew B Kahn, Richard M Cubbon, Ben Mercer, et al.
Vascular Biology (Bristol, England)|October 14, 2024
Whole-body insulin resistance leads to accelerated atherosclerosis: role for Nox2 NADPH oxidaseAzhar Maqbool, Hema Viswambharan, Anna Skromna, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2023
Independent endothelial functions of PIEZO1 and TRPV4 in hepatic portal vein and predominance of PIEZO1 in mechanical and osmotic stressNaima Endesh, Eulashini Chuntharpursat-Bon, Charlotte Revill, et al.
European Journal of Heart Failure|February 12, 2025
Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort studyHugo MacGowan, Oliver I Brown, Michael Drozd, et al.
Pageof 13